Harrow: California Accusation, Settlement Could Spur Other State Boards of Pharmacy to Take Action Against ImprimisRx
Harrow (HROW), an ophthalmic drug company, announced last week that its compounding business had reached a settlement with the California Board of Pharmacy, paying a fine of $157,000 and voluntarily surrendering its state licensure in light of an August 2025 accusation from the Board. Plaintiff Anne Sodergren, executive officer of the California Board of Pharmacy, […]














































